Description
The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis.This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology.- Provides comprehensive coverage of the different types of hepatitis- Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care- Discusses future development specific to different types of hepatitis
Table of Contents
Section 1: HEPATITIS: ADVANCES IN CLINICAL EVALUATION 1. Noninvasive assessment of liver disease severity: image-related2. Noninvasive assessments of liver disease severity based on biomarkers3. Conventional liver imaging in hepatitis4. Nutrition in liver diseaseSection II: VIRAL HEPATITIS 5. Antivirals against hepatitis viruses: basic mechanisms6. Hepatitis A and hepatitis E7. Hepatitis B: epidemiology, natural history, and diagnosis8. Hepatitis B: treatment9. Hepatitis C: epidemiology, natural history, and diagnosis10. Hepatitis C: treatment11. Hepatitis DSection III: HEPATITIS: METABOLIC, ALCOHOL, AND DRUG INDUCED12. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD13. Metabolic-associated fatty liver disease: pharmacological management14. Non-pharmacological treatment approach in patients with metabolic dysfunctionassociated liver disease15. Alcoholic hepatitis16. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method17. Introduction to drug-induced liver injurySection IV: HEPATITIS: CHOLESTATIC, GENETIC, AND AUTOIMMUNE CAUSES18. Current paradigm and treatment options for autoimmune hepatitis19. Hereditary hemochromatosis20. Wilson disease21. Alpha-1 antitrypsin deficiencySection V: HEPATITIS: INFECTIONS AND SYSTEMIC CAUSES22. Hepatitis: infections and systemic causes23. HIV: hepatic manifestations of HIV and antiretroviral therapy24. Systemic non-infectious hepatitis25. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infectionSection VI: CHILDHOOD AND PREGNANCY26. Hepatitis during childhood27. Hepatitis during pregnancy
